HRH1 and allergic disease: The ad hoc prescription of H1‐antihistamines for mild and/or nonspecific allergy symptom management in infrequent users might account for the trend of decreased mortality risk by reversing malignancy‐specific immune evasion and ICI resistance via the histamine–HRH1 axis.